Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both?

Acta Cardiologica

Volumn 65, Issue 4, 2010, Pages 415-423

  Ergelen, Mehmet ^a   Uyarel, Huseyin ^b   Cicek, Gokhan ^a   Isik, Turgay ^a   Osmonov, Damirbek ^a   Gunaydin, Zeki Yuksel ^a   Bozbay, Mehmet ^a   Turer, Ayca ^a   Gul, Mehmet ^a   Abanonu, Gul Babacan ^c   Ilhan, Erkan ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

^c Haydarpasa Numune Training Hospital   (Turkey)

Author keywords

Acute myocardial infarction; Diabetes mellitus; Hyperglycaemia; Primary angioplasty; Prognosis

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART REINFARCTION; HUMAN; HYPERGLYCEMIA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CODING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ANGIOCARDIOGRAPHY; CHI SQUARE DISTRIBUTION; COMPLICATION; FOLLOW UP; MIDDLE AGED; MYOCARDIAL INFARCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 78049275798     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.65.4.2053900     Document Type: Article

References (35)

1. Mukamal KJ, Nesto RW, Cohen MC, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001; 24: 1422-7. (Pubitemid 33716431)
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34. (Pubitemid 28350165)
3. Kasiborod M, Rathore SS, Inzucchi SE, Masoudi FA,Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-86.
4. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Randajadayalan K, Timmis AD. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 2003; 89: 512-6. (Pubitemid 36520800)
5. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, Torremocha F, Herpin D, Marechaud R. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004; 21: 305-10. (Pubitemid 38519663)
6. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748-54. (Pubitemid 35341952)
7. Bhadriraju S, Ray KK, DeFranco AC, Barber K, Bhadriraju P, Murphy SA, Morrow DA, McCabe CH, Gibson CM, Cannon CP, Braunwald E. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial. Am J Cardiol 2006; 97: 1573-7. (Pubitemid 43737031)
8. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycemia. Best Pract Res Clin Endocrinol Metab 2001; 15: 533-51.
9. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischemia and arrhytmias. Lancet 1994; 343: 155-8.
10. Vetter NJ, Adams W, Strange RC, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 303: 284-9.
11. Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, Lalli C, Ciabattoni G, Davi G, Bolli GB. Acute, short-term hyperglycemia enhances shear stres-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013-20. (Pubitemid 36315547)
12. Marfella R, Siniscalchi M, Esposito K, Sellitto A, DeFanis U, Romano C, Portoghese M, Siciliano S, Nappo F, Sasso FC, Minini N, Cacciapuoti F, Lucivero G, Giunta R. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26: 3129-35. (Pubitemid 37339509)
13. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 2005; 22: 1321-5. (Pubitemid 41391305)
14. Lavi S, Kapeliovich M, Gruberg L, Roguin A, Boulos M, Grenadier E, Amikam S, Markiewicz W, Beyar R, Hammerman H. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: Impact on long-term prognosis. Int J Cardiol 2008; 123: 117-22. (Pubitemid 350250888)
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-70.
16. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-83. (Pubitemid 43855050)
17. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
18. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-54. (Pubitemid 17093202)
19. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-8. (Pubitemid 30128815)
20. Naber CK, Mehta RH, Jünger C, Zeymer MSU, Wienbergen H, Sabin GV, Erbel R, Senges J, Gitt S. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German acute coronary syndromes (ACOS) registry. Am J Cardiol 2009; 103: 583-7.
21. Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Mielecki W, Suska M, Dubiel JS, Dudek D. Impact of admission glucose level and presence of diabetes mellitus on mortality in patients with non-ST segment elevation acute coronary syndrome treated conservatively. Am J Cardiol 2009; 103: 954-8.
22. Gasior M, Stasik-Pres G, Pres D, Lech P, Gierlotka M, Lekston A, Hawranek M, Tajstra M, Kalarus Z, Poloński L. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kardiol Pol 2007; 65: 1031-8. (Pubitemid 47358800)
23. Ishihara M, Kagawa E, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nakama Y, Maruhashi T, Ookawa K, Dai K, Aokage Y. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 2007; 99: 1674-9. (Pubitemid 46874310)
24. Kadri Z, Danchin N, Vaur L, Cottin Y, Guéret P, Zeller M, Lablanche JM, Blanchard D, Hanania G, Genès N, Cambou JP; USIC 2000 Investigators. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 2006; 92: 910-5.
25. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164: 982-8. (Pubitemid 38581518)
26. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971; 50: 1386-9.
27. Verma S, Wang CH, Weisel RD, Badiwala MV, Li SH, Fedak PW, Li RK, Mickle DA. Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. J Mol Cell Cardiol 2003; 35: 417-9. (Pubitemid 36411703)
28. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JHE, Hoorntje JCA, Gosselink ATM, Suryapranata H, Zijlstra F, van't Hof AWJ, on behalf of the Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 45: 999-1002.
29. L'Huillier I, Zeller M, Mock L, Beer JC, Laurent Y, Sicard P, Vincent-Martin M, Lorgis L, Makki H, Wolf JE, Freysz M, Cottin Y. Relation of hyperglycemia to ST-segment resolution after reperfusion for acute myocardial infarction (from Observatoire des Infarctus de Côte-d'Or Survey [RICO]). Am J Cardiol 2006; 98: 167-71. (Pubitemid 43996907)
30. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilatation in humans in vivo. Circulation 1998; 97: 1695-1701.
31. Takahashi T, Hiasa Y, Ohara Y, Miyazaki S, Mahara K, Ogura R, Miyajima H, Yuba K, Suzuki N, Hosokawa S, Kishi K, Ohtani R. Acute hyperglycaemia prevents the protective effect of pre-infarction angina on microvascular function after primary angioplasty for acute myocardial infarction. Heart 2008; 94: 1402-6.
32. Holubarsch C, Ruf T, Goldstein DJ, Ashton RC, Nickl W, Pieske B, Pioch K, Lüdemann J, Wiesner S, Hasenfuss G, Posival H, Just H, Burkhoff D. Existence of the Frank-Starling mechanism in the failing human heart: investigations on the organ, tissue, and sarcomere levels. Circulation 1996; 94: 683-9. (Pubitemid 26289222)
33. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7. (Pubitemid 36044395)
34. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, Torremocha F, Herpin D, Marechaud R. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy. J Am Coll Cardiol 2000; 35: 1502-12.
35. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapyin type 2 diabetic patients suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabetes Med 1993; 10: 27-32.